Radian Group (RDN): 93% Revenue Growth, But The Specialty Insurance Reality Check

Radian Group's Q2 revenue nearly doubled. Adjusted EPS missed consensus by 16%. The stock sits at 9 times trailing earnings and roughly book value, while analysts lean Buy and management talks up buybacks toward the higher end of its guidance range. That is the setup the headlines are selling.

The more useful framing starts with what changed, not the headline multiple. Radian stopped being a pure mortgage insurer this quarter. For the first time, the acquired specialty insurer Intego showed a full quarter of revenue, contributing $267 million in net premiums — now 53% of the company's total. The business is half specialty insurance. The valuation math has to account for that.

The factor stack

Valuation — A-grade numbers, with a twist. Radian trades at 9.1 times trailing earnings, 8.5 times forward earnings, and 1.0 times book value. Its only pure mortgage-insurance peer, MGIC Investment (MTG), sits at 8.8x trailing earnings and 1.25x book. On face value, Radian looks cheaper. The P/S multiple of 3.0 is well below MTG's 5.2. The dividend yield is 2.8%, backed by 24 consecutive years of payments and a payout ratio of just 25% — room to grow.

But "cheaper" needs context. Radian's valuation is low partly because the specialty book is dragging profitability hard, and that may not be a one-off. If the specialty combined ratio stays in the low 90s as management guided, it means for every $100 of premium, Radian pays out roughly $90-93 in claims and expenses. That is thin underwriting profit compared to the mortgage book, which posted a 35.8% combined ratio in Q2 — meaning $64.2 of underwriting profit per $100 of premium. The blended business is less profitable than the mortgage-only business it replaced.

Growth — A for revenue, C-minus for earnings. Revenue growth of 41.9% year-over-year is exceptional. But Q2 revenue of $575 million came in $6.8 million short of consensus, and adjusted EPS of $1.14 missed analyst estimates of roughly $1.35 by 15.7%. GAAP net income from continuing operations actually fell 23% year-over-year to $116 million. Free cash flow growth of 220% looks stunning in isolation — but TTM free cash flow of $1.39 billion includes the $200 million ordinary dividend upstream from Radian Guaranty (the insurance subsidiary), which is structural capital flow, not operating profit expansion.

Compare that to MGIC, whose revenue declined 1.9% but whose earnings per share have held steady around $0.75-0.87 per quarter with no major misses. Radian is betting that the specialty growth curve steepens. MGIC is showing that steady mortgage-only growth doesn't require 93% revenue acceleration to support earnings.

Profitability — D for return on capital, C-plus for ROE. Return on invested capital of negative 2.5% tells the clearest story here: the capital Radian has deployed into its specialty expansion is not yet earning a return that covers its cost of capital. ROE of 11.5% is decent but trails MGIC's 13.9%. The specialty segment generated only $29 million in adjusted pretax operating income on $504 million in gross premiums. A massive $169 million loss provision — tied to reserves for the Middle East conflict — largely wiped out what would otherwise have been a respectable quarter. Management expects the specialty combined ratio to settle in the low 90s going forward, up from the high 80s. That is a trajectory, not a rebound.

Safety — C-plus. Debt-to-equity sits at 25.6%, which looks manageable until you note that $5.85 billion in total debt includes reinsurance liabilities and the structural leverage inherent in insurance operations. Net debt of $1.23 billion is modest, and liquidity of $412 million at the holding company level is adequate. Management plans to fully repay the remaining $75 million on its revolving credit facility by year-end. The balance sheet isn't broken — it's just leveraged for a business that is still proving its specialty underwriting model.

Momentum — C-minus. The stock fell from $39.17 pre-earnings to roughly $36 today, a pullback of about 7.5%. RSI sits at 42.6 (neutral-to-bearish), price is above the 200-day moving average of $35.21 but testing the 50-day average of $36.82. Five-day performance is down 5.3%. Momentum is flat, not confirming a breakout despite the buyback activity.

What the comparison set says

No stock means anything in isolation. Against MGIC, Radian offers a growth profile that MGIC simply doesn't have: revenue accelerating 42% versus flat, P/S at 3.0 versus 5.2, and a transformation story. But MGIC's ROE is higher, its balance sheet is cleaner (12.9% debt-to-equity versus 25.6%), its FCF margin is 58.5% versus Radian's 24.4%, and its earnings have been predictable. MGIC is the anchor; Radian is the option call on diversification.

The portfolio question is which role you need. If the mortgage rate environment stays elevated — keeping refinancing low and persistency high in Radian's $284 billion in-force book — the mortgage half of Radian continues to print. The specialty half is the variable. Intego now makes up more than half the premium base, and a 97.7% combined ratio in Q2 (even with a one-time geopolitical reserve) signals that this book is sensitive to market conditions, rate softening, and unexpected events.

The buyback is real. So is the distraction.

$176 million in repurchases for 2026, with management targeting the higher end of its guidance range. Dividend upstreams of $650 million from Radian Guaranty for the full year. These numbers are genuine capital returns from a profitable subsidiary.

But buybacks can mask a transformation that is still unproven. The core mortgage business funds the dividends and repurchases. The specialty business, which now dominates the top line, is still working through margin compression and geopolitical tail risk. Radian is growing the part of the business that is the least profitable.

Verdict

Radian at 9 times earnings and book value is not a value trap — the underlying mortgage book and capital return program provide a floor. But it is not the straightforward growth story the revenue headline suggests, either. The Q2 miss was not a one-off data point; it was the first look at what a blended mortgage-specialty company looks like when specialty margins soften.

AInvest's aggregate signal labels the stock a Buy, which reflects the liquidity profile and momentum rather than the fundamental drag. The composite score of 6.44 is middling — neither conviction buy nor warning sign.

For the portfolio, Radian fits a growth-sleeve position that carries an embedded income component (2.8% yield, low payout ratio). The trigger to add is a specialty combined ratio pulling back below 92% for two consecutive quarters — that would signal the margin pressure is transitory rather than structural. The trigger to reduce is a combined ratio that stays above 97% while management continues to prioritize premium growth over underwriting discipline. The new CEO-elect, Mike Weinbach, has already signaled a shift toward margins, but the market needs to see it in the numbers before it re-rates the stock from "transformation in progress" to "transformation working."

The factor stack says hold and watch the specialty ratio. It does not yet say accelerate.